India reports a sharp decline in tuberculosis deaths, with estimates showing a thirty‑eight percent reduction between 2015 and 2025. The success rate for treating drug‑susceptible tuberculosis now stands at ninety‑four percent, aided by new diagnostic tools and comprehensive patient support. The government’s TB Mukt Bharat campaign has identified almost fifteen lakh asymptomatic cases during its operation. Health officials attribute the progress to expanded screening and timely medication. Despite the gains, drug‑resistant tuberculosis continues to pose a problem, with a noticeable gap in effective treatment options. The ministry highlighted the need to close that gap to sustain the downward trend. Ongoing efforts focus on strengthening detection and care for resistant strains.